Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
11 mars 2024 08h30 HE
|
Journey Medical Corporation
Clinical trial achieved all three primary objectives and subjects completed 16-week treatment with no significant safety issues Results indicate that DFD-29 can be safely used for up to 16 weeks with...
Alumis Presents Positive Data from Phase 2 Clinical Trial of ESK-001, an Oral Allosteric TYK2 Inhibitor for the Treatment of Plaque Psoriasis, at AAD Annual Meeting
09 mars 2024 12h00 HE
|
Alumis Inc
Alumis today announced the presentation of positive clinical data from a Phase 2 clinical trial of ESK-001 at AAD 2024.
SkinCure Oncology Unveils New Skin Cancer Treatment Technology at American Academy of Dermatology Annual Meeting in San Diego March 8-12 Booth 3555
07 mars 2024 16h35 HE
|
SkinCure Oncology LLC
BURR RIDGE, Ill., March 07, 2024 (GLOBE NEWSWIRE) -- SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy...
STRATA Skin Sciences Announces Initiative to Expand Treatment Coverage
07 mars 2024 08h00 HE
|
STRATA Skin Sciences, Inc.
HORSHAM, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and...
Provectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstract for Poster Presentation at 2024 Society for Investigative Dermatology (SID) Annual Meeting
29 févr. 2024 08h00 HE
|
Provectus Biopharmaceuticals Inc.
Preclinical Research on Full-Thickness Cutaneous Wound Healing KNOXVILLE, TN, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB:...
Derm-Biome Pharmaceuticals prepares to begin IND-enabling studies for DB-007-4, a potential best-in-class treatment for inflammatory skin diseases
27 févr. 2024 10h00 HE
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals Inc, a Vancouver-based biopharmaceutical company developing novel topical therapies for inflammatory skin...
Global Scar Treatment Market Size is Estimated to Reach USD 21,007 million by 2030, Growing at a CAGR of 9.6%: Straits Research
27 févr. 2024 07h35 HE
|
Straits Research
New York, United States, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Scarring is a specific aspect of an injury's healing process. The extent and severity of the wound or cut, the site of the damage, age,...
STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial
26 févr. 2024 16h01 HE
|
STRATA Skin Sciences, Inc.
–Amends certain financial covenants to enhance liquidity and financial flexibility– –Ensures alignment with the Company’s current and future business operations– HORSHAM, Pa., Feb. 26, 2024 (GLOBE...
LiVDerm’s 22nd Annual South Beach Symposium Achieves Outstanding Success in Miami Beach
22 févr. 2024 13h05 HE
|
LiVDerm
Boca Raton, FL, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The 2024 South Beach Symposium (SBS) and Masters of Pediatric Dermatology (MOPD) Symposiums recently came to a close in South Beach, marking a...
Infant Phototherapy Devices Market Poised for Growth: Comprehensive Analysis and Forecast 2023-2028
16 févr. 2024 07h02 HE
|
Research and Markets
Dublin, Feb. 16, 2024 (GLOBE NEWSWIRE) -- The "Global Infant Phototherapy Devices Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...